Stuart Hurst

Global Head of Market Access

On his role…

“The therapies we’re developing are based on strong science and focused on bringing a benefit to patients in need. I really love working with orphan drugs because you can potentially have a profound impact on a patient, while also being part of a start-up environment.”

On Akcea…

“The Akcea team has a natural enthusiasm and professionalism, and a kind of warmth that you don’t always see in other companies. Everyone is very engaging, inclusive, and obviously very dedicated to what they’re doing. You’re certainly encouraged to succeed on behalf of patients, like, ‘Come on! We can we get this done!’ – it’s a bit like Apollo 13!”

On what it means to be an innovator and an advocate…

“To me advocacy is an inherent part of working within orphan drug development, because it’s so individual. It’s not like you’re talking about “the hundred thousand,” you’re talking about Mrs. Jones who you know and speak to. It’s very real, it’s very direct, and I think that it’s something we take very seriously at Akcea.”